Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 1/2008

01-01-2008 | Announcement

Online First publication

Author: Springer

Published in: Breast Cancer | Issue 1/2008

Login to get access

Excerpt

With this issue of Breast Cancer, we at Springer are pleased to announce the introduction of Online First service, the quick online publication of articles shortly after receipt of the corrected proofs. …
Metadata
Title
Online First publication
Author
Springer
Publication date
01-01-2008
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2008
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-007-0021-0

Other articles of this Issue 1/2008

Breast Cancer 1/2008 Go to the issue

Conference Paper

Concepts and techniques of intraoperative radiotherapy (IORT) for breast cancer

Conference Paper

To overcome breast cancer with all of our knowledge

Conference Paper

Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer

Conference Paper

Breakthrough for neoadjuvant chemotherapy

Special Article

Results of questionnaire survey on breast cancer surgery in Japan 2004–2006

Editorial

Message from the editor-in-chief
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits